Activation-Induced Expression of CD56 by T Cells Is Associated With a Reprogramming of Cytolytic Activity and Cytokine Secretion Profile In Vitro

Lanier, 1986, The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes, J Immunol, 136, 4480, 10.4049/jimmunol.136.12.4480

Schmidt, 1986, A subset of natural killer cells in peripheral blood displays a mature T cell phenotype, J Exp Med, 164, 351, 10.1084/jem.164.1.351

Ortaldo, 1991, Comparative studies of CD3− and CD3+ CD56+ cells: examination of morphology, functions, T cell receptor rearrangement, and pore-forming protein expression, Cell Immunol, 136, 486, 10.1016/0008-8749(91)90369-M

Dunne, 2001, Selective expansion and partial activation of human NK cells and NK receptor-positive T cells by IL-2 and IL-15, J Immunol, 167, 3129, 10.4049/jimmunol.167.6.3129

Ohkawa, 2001, Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells, Immunology, 103, 281, 10.1046/j.1365-2567.2001.01248.x

Norris, 1999, Natural T cells in the human liver: cytotoxic lymphocytes with dual T cell and natural killer cell phenotype and function are phenotypically heterogenous and include Vα24-JαQ and γδ T cell receptor bearing cells, Hum Immunol, 60, 20, 10.1016/S0198-8859(98)00098-6

Ishihara, 1999, CD8+ NKR-P1A+ T cells preferentially accumulate in human liver, Eur J Immunol, 29, 2406, 10.1002/(SICI)1521-4141(199908)29:08<2406::AID-IMMU2406>3.0.CO;2-F

Bannai, 2001, Abundance of unconventional CD8+ natural killer T cells in the large intestine, Eur J Immunol, 31, 3361, 10.1002/1521-4141(200111)31:11<3361::AID-IMMU3361>3.0.CO;2-Z

Iiai, 2002, CD161+ T (NT) cells exist predominantly in human intestinal epithelium as well as in liver, Clin Exp Immunol, 129, 92, 10.1046/j.1365-2249.2002.01886.x

O’Keeffe, 2004, Diverse populations of T cells with NK cell receptors accumulate in the human intestine in health and in colorectal cancer, Eur J Immunol, 34, 2110, 10.1002/eji.200424958

Lu, 1994, A novel population of expanded human CD3+ CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency, J Immunol, 153, 1687, 10.4049/jimmunol.153.4.1687

Pittet, 2000, Cutting edge: cytolytic effector function in human circulating CD8+ T cells closely correlates with CD56 surface expression, J Immunol, 164, 1148, 10.4049/jimmunol.164.3.1148

Loza, 2002, NKT and T cells: coordinate regulation of NK-like phenotype and cytokine production, Eur J Immunol, 32, 3453, 10.1002/1521-4141(200212)32:12<3453::AID-IMMU3453>3.0.CO;2-D

Satoh, 1996, Cytotoxic γδ or αβ T cells with a natural killer cell marker, CD56, induced from human peripheral blood lymphocytes by a combination of IL-12 and IL-2, J Immunol, 157, 3886, 10.4049/jimmunol.157.9.3886

Jin, 1998, The regulation of phenotype and function of human liver CD3+/CD56+ lymphocytes, and cells that also co-express CD8 by IL-2, IL-12 and anti-CD3 monoclonal antibody, Hum Immunol, 59, 352, 10.1016/S0198-8859(98)00030-5

Zoll, 1998, Generation of cytokine-induced killer cells using exogenous interleukin-2, -7 or -12, Cancer Immunol Immunother, 47, 221, 10.1007/s002620050524

Kelly, 2004, Interleukin 12 (IL-12) is increased in tumour bearing human liver and expands CD8+ and CD56+ T cells in vitro but not in vivo, Cytokine, 25, 273, 10.1016/j.cyto.2003.11.012

Schmidt-Wolf, 1993, Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cells, Exp Hematol, 21, 1673

Linn, 2003, Cytokine-induced killer cells: NK-like T cells with cytotolytic specificity against leukemia, Leuk Lymphoma, 44, 1457, 10.3109/10428190309178764

Schmidt-Wolf, 1999, Phase I clinical study applying autologous immunologic effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma, Br J Cancer, 81, 1009, 10.1038/sj.bjc.6690800

Shi, 2004, Autologous cytokine-induced killer cell therapy in clinical trial phase I is safe in patients with primary hepatocellular carcinoma, World J Gastroenterol, 10, 1146, 10.3748/wjg.v10.i8.1146

Leemhuis, 2005, A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphoma, Biol Blood Marrow Transplant, 11, 181, 10.1016/j.bbmt.2004.11.019

Barnaba, 1994, Selective expansion of cytotoxic T lymphocytes with a CD4+ CD56+ surface phenotype and a T helper type 1 profile of cytokine secretion in the liver of patients chronically infected with Hepatitis B virus, J Immunol, 152, 3074, 10.4049/jimmunol.152.6.3074

Prussin, 1997, TCR Vα24 and Vβ11 coexpression defines a human NK1 T cell analog containing a unique Th0 subpopulation, J Immunol, 159, 5862, 10.4049/jimmunol.159.12.5862

Doherty, 1999, The human liver contains multiple populations of NK cells, T cells, and CD3+ CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns, J Immunol, 163, 2314, 10.4049/jimmunol.163.4.2314

Carding, 2002, γδ T cells: functional plasticity and heterogeneity, Nat Rev Immunol, 2, 336, 10.1038/nri797

Kronenberg, 2005, Toward an understanding of NKT cell biology: progress and paradoxes, Annu Rev Immunol, 23, 877, 10.1146/annurev.immunol.23.021704.115742

Takii, 1994, Increase in the proportion of granulated CD56+ T cells in patients with malignancy, Clin Exp Immunol, 97, 522, 10.1111/j.1365-2249.1994.tb06120.x

Meresse, 2006, Reprogramming of CTLs into natural killer-like cells in celiac disease, J Exp Med, 203, 1343, 10.1084/jem.20060028

Deignan, 2002, Decrease in hepatic CD56+ T cells and Vα24+ natural killer T cells in chronic hepatitis C viral infection, J Hepatol, 37, 101, 10.1016/S0168-8278(02)00072-7

Tarazona, 2002, Selective depletion of CD56dim NK cell subsets and maintenance of CD56bright NK cells in treatment-naive HIV-1-seropositive individuals, J Clin Immunol, 22, 176, 10.1023/A:1015476114409

Norris, 2003, Selective reduction of natural killer cells and T cells expressing inhibitory receptors for MHC class I in the livers of patients with hepatic malignancy, Cancer Immunol Immunother, 52, 53, 10.1007/s00262-002-0331-1

Mingari, 1995, Cytolytic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production, Int Immunol, 7, 697, 10.1093/intimm/7.4.697

Mandelboim, 1998, Natural killer activating receptors trigger interferon-γ secretion from T cells and natural killer cells, Proc Natl Acad Sci USA, 95, 3798, 10.1073/pnas.95.7.3798

McMahon, 2001, Expression and function of NK cell receptors in CD8+ T cells, Curr Opin Immunol, 13, 465, 10.1016/S0952-7915(00)00242-9

Speiser, 1999, CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients, Eur J Immunol, 29, 1990, 10.1002/(SICI)1521-4141(199906)29:06<1990::AID-IMMU1990>3.0.CO;2-9

Ugolini, 2001, Involvement of inhibitory NKRs in the survival of a subset of memory-phenotype CD8+ T cells, Nat Immunol, 2, 430, 10.1038/87740

Brigl, 2004, CD1: antigen presentation and T cell function, Annu Rev Immunol, 22, 817, 10.1146/annurev.immunol.22.012703.104608

Exley, 1997, Requirements for CD1d recognition by human invariant Vα24+ CD4−CD8− T cells, J Exp Med, 186, 109, 10.1084/jem.186.1.109

Sonoda, 2001, NK T cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance, J Immunol, 166, 42, 10.4049/jimmunol.166.1.42

Ferrick, 1995, Differential production of interferon-γ and interleukin-4 in response to Th1- and Th2-stimulating pathogens by γδ T cells in vivo, Nature, 373, 255, 10.1038/373255a0

Hsieh, 1996, In vivo cytokine production in murine listeriosis, J Immunol, 156, 232, 10.4049/jimmunol.156.1.232

Anfossi, 2004, Coordinated expression of Ig-like inhibitory MHC class I receptors and acquisition of cytotoxic function in human CD8+ T cells, J Immunol, 173, 7223, 10.4049/jimmunol.173.12.7223

Anfossi, 2004, Expansion and function of CD8+ T cells expressing Ly49 inhibitory receptors specific for MHC class I molecules, J Immunol, 173, 3773, 10.4049/jimmunol.173.6.3773

Kambayashi, 2000, Emergence of CD8+ T cells expressing NK cell receptors in influenza A virus-infected mice, J Immunol, 165, 4964, 10.4049/jimmunol.165.9.4964

Huse, 2006, T cells use two directionally distinct pathways for cytokine secretion, Nat Immunol, 7, 247, 10.1038/ni1304

Leslie, 2002, CD1-mediated gd T cell maturation of dendritic cells, J Exp Med, 196, 1575, 10.1084/jem.20021515

Vincent, 2002, CD1-dependent dendritic cell instruction, Nat Immunol, 3, 1163, 10.1038/ni851

Mills, 2004, Regulatory T cells: friend or foe in immunity to infection?, Nat Rev Immunol, 4, 841, 10.1038/nri1485